Abaxis
This article was originally published in The Gray Sheet
Executive Summary
Plans to submit a 510(k) for its EPOC 2000 blood-chemistry analyzer during the third quarter of 1993. The EPOC 2000 is a point-of-care diagnostic instrument that can perform multiple blood tests in under 10 minutes ("The Gray Sheet" Dec. 23, 1991, p. 5). The 510(k) filing will cover five tests, and the firm says that a second filing for a "full complement of tests" will take place following FDA clearance of the original 510(k). Abaxis recently revised the rotor of the EPOC 2000 to correct deficiencies seen with a prototype version of the device. The redesigned device can separate the patient's whole blood and measure the plasma sample with "the desired level of accuracy," the firm says.
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.